3 studies found for:    nilotinib AND GIST | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Study of Nilotinib Versus Imatinib in GIST Patients
Condition: Gastrointestinal Stromal Tumor (GIST)
Interventions: Drug: Nilotinib (AMN107);   Drug: imatinib (STI571)
2 Recruiting Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Condition: GIST and CML
Intervention: Drug: AMN107
3 Recruiting A Global Imatinib and Nilotinib Pregnancy Exposure Registry
Condition: All Indications for Glivec/Gleevec and Tasigna
Interventions: Drug: Tasigna;   Drug: Gleevec

Indicates status has not been verified in more than two years